Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GHSR agonists(Ghrelin/growth hormone secretagogue receptor agonists), SMPD1 inhibitors(sphingomyelin phosphodiesterase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H28N4O2 |
InChIKeyZPXWKEHHIIOEAC-UHFFFAOYSA-N |
CAS Registry2376132-22-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | KR | 18 Jan 2022 |